
Bio-Rad Laboratories, Inc.Class A
BIO Real Time Price USDRecent trades of BIO by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by BIO's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$80,000 Apr 17, 2025 Issue: Health Issues Defense
-
$80,000 Jan 17, 2025 Issue: Health Issues Defense
-
$80,000 Oct 17, 2024 Issue: Defense Health Issues
-
$80,000 Jul 14, 2024 Issue: Defense Health Issues
-
$80,000 Apr 12, 2024 Issue: Defense Health Issues
-
$80,000 Oct 18, 2023 Issue: Defense Health Issues
-
$80,000 Jul 16, 2023 Issue: Health Issues
-
$80,000 Jan 15, 2023 Issue: Health Issues
-
$80,000 Oct 17, 2022 Issue: Health Issues
-
$80,000 Jul 15, 2022 Issue: Health Issues
-
$80,000 Apr 15, 2022 Issue: Health Issues
-
$80,000 Jan 16, 2022 Issue: Health Issues
-
$80,000 Oct 15, 2021 Issue: Health Issues
-
$80,000 Jul 17, 2021 Issue: Health Issues
-
$80,000 Apr 19, 2021 Issue: Health Issues
-
$100,000 Jan 19, 2021 Issue: Health Issues Budget/Appropriations
-
$100,000 Oct 19, 2020 Issue: Health Issues Budget/Appropriations
-
$50,000 Jul 18, 2020 Issue: Health Issues
Estimated quarterly lobbying spending
BIO Revenue by Segment or Geography
New patents grants
-
Patent Title: Mixed mode cation exchange chromatography ligands based on 1,3-dioxoisoindolin-2-yl structures Apr. 01, 2025
-
Patent Title: Method and composition for quantifying protein using tagged standards Mar. 25, 2025
-
Patent Title: Digital analyte analysis Mar. 04, 2025
-
Patent Title: System and method for droplet detection Mar. 04, 2025
-
Patent Title: Mda using bead oligonucleotide Feb. 18, 2025
-
Patent Title: System for imaging captured cells Feb. 11, 2025
-
Patent Title: Methods of cdna preparation Feb. 11, 2025
-
Patent Title: Modified reverse transcriptases Feb. 11, 2025
-
Patent Title: Methods and compositions for deconvoluting partition barcodes Jan. 28, 2025
-
Patent Title: Microfluidic probe head with aspiration posts Jan. 21, 2025
-
Patent Title: Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand Jan. 14, 2025
-
Patent Title: Cell barcoding for single cell sequencing Dec. 31, 2024
-
Patent Title: Method of analysis Dec. 17, 2024
-
Patent Title: Preparation of nucleated rbc (nrbc) analogs for use as reference hematology controls in automated hematology analyzers Dec. 10, 2024
-
Patent Title: Hybrid reverse transcriptases Dec. 10, 2024
-
Patent Title: System and method for target detection with applications in characterizing food quality and improving food safety Dec. 10, 2024
-
Patent Title: Partition-based method of analysis Dec. 10, 2024
-
Patent Title: System and method for retrieving and analyzing particles Nov. 26, 2024
-
Patent Title: System and method for conducting virtual crossover studies in clinical diagnostic processes Nov. 19, 2024
-
Patent Title: Microfluidic devices and methods of use in the formation and control of nanoreactors Nov. 19, 2024
-
Patent Title: Compositions and methods for molecular labeling Nov. 12, 2024
-
Patent Title: Compositions and methods for molecular labeling Nov. 12, 2024
-
Patent Title: Structures on microfluidic devices to control sedimentation Oct. 29, 2024
-
Patent Title: Method of emulsion formation and modification Oct. 01, 2024
-
Patent Title: Methods and compositions for detecting genetic material Sep. 24, 2024
-
Patent Title: Systems and methods for handling microfluidic droplets Sep. 17, 2024
-
Patent Title: Partition-based method of analysis Sep. 17, 2024
-
Patent Title: Adjustable digital microscope display Sep. 10, 2024
-
Patent Title: System and method for retrieving and analyzing particles Aug. 20, 2024
-
Patent Title: Reverse transcriptases and uses thereof Aug. 20, 2024
-
Patent Title: System and method for rapid multiplexed sample processing with applications for nucleic acid amplification assays Aug. 20, 2024
-
Patent Title: Container rotation device Aug. 20, 2024
-
Patent Title: System and method for retrieving and analyzing particles Jul. 23, 2024
-
Patent Title: Enzyme quantification Jul. 16, 2024
-
Patent Title: Digital analyte analysis Jul. 09, 2024
-
Patent Title: System and method for capturing and analyzing cells Jul. 09, 2024
-
Patent Title: Amplification reporter with base-pairing oligomers Jul. 02, 2024
-
Patent Title: Liquid level determination Jun. 25, 2024
-
Patent Title: Contact imaging of standards with illumination Jun. 18, 2024
-
Patent Title: Microfluidic probe head with barrier projections Jun. 18, 2024
-
Patent Title: Digital assays with a generic reporter Jun. 11, 2024
-
Patent Title: High precision and low cross-coupling laser steering May. 14, 2024
-
Patent Title: Lateral flow pump housing May. 14, 2024
-
Patent Title: Digital protein quantification Apr. 23, 2024
-
Patent Title: Compositions and methods for molecular labeling Apr. 23, 2024
-
Patent Title: Electronic component assembly with thermally conductive structures for image sensors Apr. 09, 2024
-
Patent Title: Sandwich assays in droplets Apr. 02, 2024
-
Patent Title: Cell capture system and method of use Apr. 02, 2024
-
Patent Title: Methods and compositions for nucleic acid analysis Mar. 26, 2024
-
Patent Title: Synthesizing barcoding sequences utilizing phase-shift blocks and uses thereof Mar. 12, 2024
Federal grants, loans, and purchases
- $17,352 2025-07-09 00:00:00 Agency: Department of Health and Human Services
- $49,383 2025-07-02 00:00:00 Agency: Department of Veterans Affairs
- $5,900 2025-07-02 00:00:00 Agency: Department of the Interior
- $19,373 2025-06-26 00:00:00 Agency: Department of Agriculture
- $24,947 2025-06-26 00:00:00 Agency: Department of Health and Human Services
- $24,869 2025-06-16 00:00:00 Agency: Department of Health and Human Services
- $39,280 2025-06-12 00:00:00 Agency: Department of Agriculture
- $50,834 2025-06-10 00:00:00 Agency: Department of Health and Human Services
- $28,292 2025-05-28 00:00:00 Agency: Department of Health and Human Services
- $24,883 2025-05-07 00:00:00 Agency: Department of Health and Human Services
- $10,783 2025-04-28 00:00:00 Agency: Department of Health and Human Services
- $16,800 2025-04-24 00:00:00 Agency: National Aeronautics and Space Administration
- $23,203 2025-04-16 00:00:00 Agency: Department of Health and Human Services
- $20,418 2025-04-08 00:00:00 Agency: Department of Health and Human Services
- $21,426 2025-03-27 00:00:00 Agency: Department of Health and Human Services
- $12,444 2025-03-25 00:00:00 Agency: Department of Health and Human Services
- $23,203 2025-03-21 00:00:00 Agency: Department of Health and Human Services
- $16,116 2025-03-17 00:00:00 Agency: Environmental Protection Agency
- $11,995 2025-02-20 00:00:00 Agency: Environmental Protection Agency
- $0 2025-01-31 00:00:00 Agency: Department of Energy
- $23,115 2024-12-19 00:00:00 Agency: Department of Health and Human Services
- $10,783 2024-12-06 00:00:00 Agency: Department of Health and Human Services
- $35,720 2024-12-05 00:00:00 Agency: Department of Health and Human Services
- $35,720 2024-12-05 00:00:00 Agency: Department of Health and Human Services
- $10,783 2024-11-27 00:00:00 Agency: Department of Health and Human Services
- $36,791 2024-11-19 00:00:00 Agency: Department of Health and Human Services
- $25,080 2024-10-25 00:00:00 Agency: Environmental Protection Agency
- $27,265 2024-10-22 00:00:00 Agency: Department of Veterans Affairs
- $12,625 2024-09-20 00:00:00 Agency: Department of Health and Human Services
- $12,625 2024-09-20 00:00:00 Agency: Department of Health and Human Services
- $37,300 2024-09-17 00:00:00 Agency: Department of Health and Human Services
- $37,300 2024-09-17 00:00:00 Agency: Department of Health and Human Services
- $19,217 2024-09-15 00:00:00 Agency: Department of Health and Human Services
- $19,217 2024-09-15 00:00:00 Agency: Department of Health and Human Services
- $24,631 2024-09-10 00:00:00 Agency: Department of Health and Human Services
- $24,000 2024-09-08 00:00:00 Agency: Department of Health and Human Services
- $19,961 2024-09-06 00:00:00 Agency: Department of Health and Human Services
- $24,336 2024-09-05 00:00:00 Agency: Department of Health and Human Services
- $230,810 2024-09-04 00:00:00 Agency: Department of Health and Human Services
- $18,432 2024-09-03 00:00:00 Agency: Department of Commerce
- $11,264 2024-08-30 00:00:00 Agency: Department of Health and Human Services
- $26,218 2024-08-28 00:00:00 Agency: Department of Veterans Affairs
- $23,808 2024-08-22 00:00:00 Agency: Department of Health and Human Services
- $10,140 2024-08-22 00:00:00 Agency: Department of Agriculture
- $16,896 2024-08-16 00:00:00 Agency: Department of Health and Human Services
- $17,613 2024-08-16 00:00:00 Agency: Department of Health and Human Services
- $63,189 2024-08-14 00:00:00 Agency: Department of Health and Human Services
- $83,100 2024-08-13 00:00:00 Agency: Department of Health and Human Services
- $21,642 2024-08-12 00:00:00 Agency: Department of Health and Human Services
- $29,460 2024-08-09 00:00:00 Agency: Department of Health and Human Services
Estimated quarterly amount awarded from public contracts
Recent insights relating to BIO
Recent picks made for BIO stock on CNBC
ETFs with the largest estimated holdings in BIO
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
---|
- Is $BIO stock a Buy, Sell, or Hold?
- What is the price target for $BIO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
Shareholder
|
Shares Held
|
---|
- Who owns $BIO stock?
- Who owns the most shares of $BIO stock?
- What funds own $BIO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BIO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.